Selvita will be exhibiting at the 5th MassBio CRO/CMO Symposium

Krakow, Poland – December 1, 2016 – Selvita will be exhibiting at the 5th Annual  MassBio CRO/CMO Symposium at the Boston Marriott Cambridge, on Thursday, December 8, 2016. This symposium brings together participants from the Boston life sciences cluster to discuss the best practices required to reduce time to market….

More

Selvita presents posters at 2016 EORTC-NCI-AACR Symposium

Kraków, Poland – November 30, 2016 – Selvita will present posters reporting results from two of its most advanced research programs at the 2016 EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, taking place on November 29, 2016, in Munich, Germany. The following posters will be presented at the Molecular Targeted Agents II session, on…

More

Selvita shows 26% business growth in Q3 2016

Krakow, Poland – 23 November 2016 – Selvita, the largest drug discovery company in Central and Eastern Europe, has published quarterly financial results showing outstanding business performance across all segments. Net sales revenues (excl. grants) rose from PLN 10.3 MM in Q3 2015 to PLN 17.7 MM in Q3 2016,…

More

Selvita exhibits at 34th Medicinal Chemistry Symposium in Japan

Kraków, Poland – 23 November 2016 – Selvita will participate and exhibit during the upcoming 34th Medicinal Chemistry Symposium, which will take place in Tsukuba, Japan, from November 30 to December 2, 2016. This symposium provides superb opportunities for participants to expand scientific knowledge and information on medicinal chemistry, and also to…

More

Selvita presents at Inv€$tival Showcase in London

Kraków, 03 November 2016 – Selvita will participate and present at the Biotech and Money Inv€$tival Showcase, taking place on November 18, in London, UK. Biotech and Money Inv€$tival Showcase, co-located with the Jefferies 2016 London Healthcare Conference in London, on November 18, showcases the latest investable public and private life…

More

...89101112...